Can we with vitamin D, improve the immune system?
- Conditions
- Immunological problems such as hypogammaglobulinemia with clinical recurrent infections such as sinusitis , pneumonia , otitis , skin infections and gastrointestinal infections.Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Registration Number
- EUCTR2016-003673-18-BE
- Lead Sponsor
- Z Brussel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- A
- Sex
- All
- Target Recruitment
- Not specified
Application for a Toll-like receptor research because of immunological problems such as hypogammaglobulinemia with clinical recurrent infections such as sinusitis, pneumonia, otitis, skin infections and gastrointestinal infections. No distinction is made in this study on the gender or age.
Are the trial subjects under 18? yes
Number of subjects for this age range: 100
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
In case of refusal of the patient or parents.
Patient with sarcoidosis or disease Besnier-Book Schaumann.
Known hypersensitivity to any of the ingredients in the drug.
Hypercalcemia and in particular idiopathic hypercalcemia in infants.
Hypercalciuria and, in particular, when it is accompanied with renal lithiasis.
Patients with renal insufficiency, lithiasis or heart disease because these patients have a higher risk of hypercalcaemia.
Patients taking drugs such as digitalis preparations, thiazide diuretics, phenytoin, carbamazepine and prymidone.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method